Patents by Inventor Jean-Fran.cedilla.ois Rossignol

Jean-Fran.cedilla.ois Rossignol has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Acid stabilized pharmaceutical compositions of tizoxanide and nitazoxanide
    Patent number: 6117894
    Abstract: The present invention relates to a pharmaceutical composition containing as active agent, solid particles of a compound selected from the group consisting of:compound of formula I: ##STR1## compound of formula II: ##STR2## and mixtures thereof. said particles having a particle size smaller than 200 .mu.m, the mean particle size of the said active solid particles being greater than 10 .mu.m.It also relates to a pharmaceutical composition which contains at least one pharmaceutically acceptable acid.
    Type: Grant
    Filed: May 6, 1998
    Date of Patent: September 12, 2000
    Assignee: Romark Laboratories, L.C.
    Inventor: Jean-Fran.cedilla.ois Rossignol
  • Pharmaceutical compositions of tizoxanide and nitazoxanide
    Patent number: 5968961
    Abstract: The present invention relates to a pharmaceutical composition containing as active agent, solid particles of a compound selected from the group consisting of:compound of formula I ##STR1## and mixtures thereof, said particles having a particle size smaller than 200 .mu.m, the mean particle size of the said active solid particles being greater than 10 .mu.m.It also relates to a pharmaceutical composition which contains at least one pharmaceutically acceptable acid.
    Type: Grant
    Filed: May 7, 1997
    Date of Patent: October 19, 1999
    Assignee: Romark Laboratories, L.C.
    Inventor: Jean-Fran.cedilla.ois Rossignol
  • Method for treatment of opportunistic infections with pharmaceutical compositions of tizoxanide and nitazoxanide
    Patent number: 5965590
    Abstract: Methods for treatment of Cryptosporidium parvum, Isospora belli, Enterocytzoon bieneusi, Encephalitozoon intestinalis, Mycobacterium tuberculosis, Mycobacterium avium intracellulare, Pneumocystis carinii, and Toxoplasma gondii, the methods comprising the administration of a pharmaceutical composition containing as active agent at least one compound selected the group consisting of a compound of formula I: ##STR1## and a compound of formula II: ##STR2##
    Type: Grant
    Filed: July 3, 1997
    Date of Patent: October 12, 1999
    Inventor: Jean-Fran.cedilla.ois Rossignol
  • Method for treatment of equine protozoal myeloencephalitis with thiazolides
    Patent number: 5935591
    Abstract: A method for treatment or prevention of equine protozoal myeloencephalitis, a condition for which there is presently no effective treatment. The method comprises administering to the infected horse an amount of one or more 2-benzamido-5-nitro-thiazole compounds sufficient to eradicate Sarcocystis spp.
    Type: Grant
    Filed: January 15, 1998
    Date of Patent: August 10, 1999
    Assignee: Romark Laboratories, L.C.
    Inventors: Jean-Fran.cedilla.ois Rossignol, Marc S. Ayers
  • Synthesis of aryl glucuronide of 2-hydroxy-N- (5-nitro-2-thiazolyl) benzamide, and pharmaceutical compositions comprising same
    Patent number: 5925622
    Abstract: An aryl glucuronide of 2-hydroxy-N-(5-nitro-2-thiazolyl)benzamide, preferably an O-aryl glucuronide, as well as methods for the convenient synthesis of these aryl glucuronides, highly stable and low toxicity pharmaceutical composition containing these aryl glucuronides, and methods for use of these pharmaceutical compositions, for example, for treatment of inflammation, infections, etc.
    Type: Grant
    Filed: July 13, 1998
    Date of Patent: July 20, 1999
    Assignee: Romark Laboratories, L.C.
    Inventors: Jean-Fran.cedilla.ois Rossignol, Marc S. Ayers
  • Method for treatment of helicobacter pylori infections
    Patent number: 5859038
    Abstract: The present invention relates to a method for treating helicobacter pylori bacteria or for preventing troubles or diseases or infections due to helicobacter pylori bacteria, said method comprising administering to a subject an effective amount of a compound selected in the group consisting of:compound A of formula ##STR1## compound B of formula ##STR2## and mixture of said compounds A and B.
    Type: Grant
    Filed: May 10, 1996
    Date of Patent: January 12, 1999
    Assignee: Romark Laboratories, L.C.
    Inventor: Jean-Fran.cedilla.ois Rossignol